Novel Immune Signals and Atherosclerosis
Author:
Publisher
Springer Science and Business Media LLC
Subject
Cardiology and Cardiovascular Medicine
Link
http://link.springer.com/content/pdf/10.1007/s11883-012-0267-7.pdf
Reference70 articles.
1. Ross R, Glomset JA. Atherosclerosis and the arterial smooth muscle cell: proliferation of smooth muscle is a key event in the genesis of the lesions of atherosclerosis. Science. 1973;180:1332–9.
2. Blake GJ, Ridker PM. Novel clinical markers of vascular wall inflammation. Circ Res. 2001;89:763–71.
3. Kaptoge S, Di Angelantonio E, Lowe G, Pepys MB, Thompson SG, Collins R, et al. C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis. Lancet. 2010;375:132–40.
4. Ridker PM. The time for cardiovascular inflammation reduction trials has arrived: how low to go for hscrp? Arterioscler Thromb Vasc Biol. 2008;28:1222–4.
5. Rubin J, Chang HJ, Nasir K, Blumenthal RS, Blaha MJ, Choi EK, et al. Association between high-sensitivity c-reactive protein and coronary plaque subtypes assessed by 64-slice coronary computed tomography angiography in an asymptomatic population. Circ Cardiovasc Imaging. 2011;4:201–9.
Cited by 18 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Atherosclerosis Potential Drug Targets: Current Scenario and Future Perspectives;Cardiovascular & Hematological Disorders-Drug Targets;2023-06
2. ERCC5 , HES6 and RORA are potential diagnostic markers of coronary artery disease;FEBS Open Bio;2022-08-07
3. Mechanism overview and target mining of atherosclerosis: Endothelial cell injury in atherosclerosis is regulated by glycolysis (Review);International Journal of Molecular Medicine;2020-11-24
4. Inflammatory Biomarkers for Cardiovascular Risk Stratification in Familial Hypercholesterolemia;Reviews of Physiology, Biochemistry and Pharmacology;2020
5. Animal Models of Obesity Characterized by Non-alcoholic Fatty Liver Disease (NAFLD);Experimental Animal Models of Human Diseases - An Effective Therapeutic Strategy;2018-05-23
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3